Fitzgerald Industries International, Inc. CA 19-9 antibody 10-C04E

Description
Mouse monoclonal CA 19-9 antibody Background: CA19-9 (carbohydrate antigen 19-9 or sialylated Lewis (a) antigen) is a blood test from the tumor marker category. It was discovered in patients with colon cancer and pancreatic cancer in 1981. Increased levels of CA19-9 are also found in non-malignant conditions, such as Mirizzi's syndrome and diseases of the bile ducts and liver.
Description
Mouse monoclonal CA 19-9 antibody Background: CA19-9 (carbohydrate antigen 19-9 or sialylated Lewis (a) antigen) is a blood test from the tumor marker category. It was discovered in patients with colon cancer and pancreatic cancer in 1981. Increased levels of CA19-9 are also found in non-malignant conditions, such as Mirizzi's syndrome and diseases of the bile ducts and liver.

Suppliers

Company
Product
Description
Supplier Links
Fitzgerald Industries International, Inc.
Acton, MA, USA
CA 19-9 antibody
10-C04E
CA 19-9 antibody 10-C04E
Mouse monoclonal CA 19-9 antibody Background: CA19-9 (carbohydrate antigen 19-9 or sialylated Lewis (a) antigen) is a blood test from the tumor marker category. It was discovered in patients with colon cancer and pancreatic cancer in 1981. Increased levels of CA19-9 are also found in non-malignant conditions, such as Mirizzi's syndrome and diseases of the bile ducts and liver.

Mouse monoclonal CA 19-9 antibody
Background:
CA19-9 (carbohydrate antigen 19-9 or sialylated Lewis (a) antigen) is a blood test from the tumor marker category. It was discovered in patients with colon cancer and pancreatic cancer in 1981. Increased levels of CA19-9 are also found in non-malignant conditions, such as Mirizzi's syndrome and diseases of the bile ducts and liver.

Supplier's Site

Technical Specifications

  Fitzgerald Industries International, Inc.
Product Category Biological Materials
Product Number 10-C04E
Product Name CA 19-9 antibody
Unlock Full Specs
to access all available technical data

Similar Products